Meds Entry Watch - New Medicines Approved in 2020

Ansuvimab-zykl (Ebanga)^B,O

Indicated to treat Ebola²

Ridgeback Biotherapeutics

Atoltivimab, maftivimab, and odesivimab-ebgn (Inmazeb)^B,O

Indicated to treat Ebola²

Jazz Pharmaceuticals

Avapritinib (Ayvakyt)^C,O

Indicated to treat adults with unresectable or metastatic gastrointestinal stromal tumor (GIST)²

Blueprint Medicines Corporation

Belantamab mafodotin (Blenrep)^B,C,O

Indicated to treat multiple myeloma²

GlaxoSmithKline

Bempedoic acid (Nexletol)

Indicated to treat adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C²

Esperion Therapeutics, Inc.

Berotralstat (Orladeyo)^B

Indicated to treat patients with hereditary angioedema²

BioCryst Pharmaceuticals, Inc.

Brexucabtagene autoleucel (Tecartus)^B,C,G,O

Indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL)²

Kite Pharma, Inc.

Bulevirtide (Hepcludex)^B,O

Indicated to treat chronic (long-term) hepatitis delta virus (HDV) infection in adults with compensated liver disease (when the liver is damaged but is still able to work), when the presence of viral RNA (genetic material) has been confirmed by blood tests.³

Gilead Sciences Ireland UC

 Cabotegravir (Vocabria)

Indicated for short-term treatment of human immunodeficiency virus type
1 (HIV-1) infection¹

ViiV Healthcare ULC

Capmatinib (Tabrecta)^C,O

Indicated to treat patients with non-small-cell lung cancer²

Novartis Pharmaceuticals Corp.

Cedazuridine (Inqovi)^C,O

Indicated to treat adult patients with myelodysplastic syndromes¹

Otsuka Pharmaceutical Co., Ltd

Clascoterone (Winlevi)

Indicated to treat acne²

Sun Pharmaceutical Industries Ltd

Coagulation factor VIIa (Recombinant) (Sevenfact) ^B

Indicated for treatment and control of bleeding episodes occurring in adults and adolescents (12 years of age and older) with hemophilia A or B with inhibitors²

Laboratoire francais du fractionnement et des biotechnologies S.A.

COVID-19 MRNA vaccine (Comirnaty)B

Indicated for preventing coronavirus disease 2019 (COVID-19) in people aged 5 years and older³

BioNTech Manufacturing GmbH

Eptinezumab (Vyepti)^B

Indicated for the preventive treatment of migraine in adults²

Lundbeck Seattle BioPharmaceuticals, Inc.

Filgotinib (Jyseleca)^B

Indicated for treating adults with moderate to severe rheumatoid arthritis³

Gilead Sciences Ireland UC

Fostemsavir trometamol (Rukobia)

Indicated to treat HIV²

ViiV Healthcare ULC

Imlifidase (Idefirix)^B

Indicated to prevent the body from rejecting a newly transplanted kidney³

Hansa Biopharma AB

Inebilizumab (Uplizna)^B,O

Indicated to treat neuromyelitis optica spectrum disorder²

Viela Bio, Inc.

Isatuximab (Sarclisa)^B,C,O

Indicated to treat multiple myloma¹

Sanofi-Aventis Canada Inc.

Lonafarnib (Zokinvy)^O

Indicated to treat rare conditions related to premature aging ²

Eiger BioPharmaceuticals

Lumasiran (Oxlumo)^O

Indicated to treat hyperoxaluria type 1²

Alnylam Pharmaceuticals Inc.

Lurbinectedin (Zepzelca)^C,O

Indicated to treat metastatic small cell lung cancer²

Jazz Pharmaceuticals

Naxitamab (Danyelza)^B,C,O

Indicated to treat high-risk refractory or relapsed neuroblastoma²

Y-mAbs Therapeutics, Inc.

Oliceridine (Olinvyk)

Indicated to manage acute pain in certain adults²

Trevena Inc.

Osilodrostat (Isturisa)^O

Indicated to treat adults with Cushing’s disease who either cannot undergo pituitary gland surgery or have undergone the surgery but still have the disease²

Recordati Rare Diseases Inc.

Ozanimod (Zeposia)

Indicated to treat relapsing forms of multiple sclerosis¹

Celgene Inc.

Pemigatinib (Pemazyre)^C,O

Indicated to treat certain patients with cholangiocarcinoma, a rare form of cancer that forms in bile ducts²

Incyte Corp.

Pralsetinib (Gavreto)^C,O

Indicated to treat non-small-cell lung cancer²

Genentech USA, Inc.

Relugloix (Orgovyx)^C

Indicated to treat advanced prostate cancer²

Myovant Sciences Ltd

Remdesivir (Veklury)

Indicated to treat COVID-19¹

Gilead Sciences Canada Inc.

Remimazolam (Anerem)

Indicated for sedation²

Acacia Pharma Ltd

Rimegepant (Nurtec)

Indicated to treat migraine²

Biohaven Pharmaceuticals

Ripretinib (Qinlock)^C,O

Indicated to treat advanced gastrointestinal-stromal tumors¹

Deciphera Pharmaceuticals, LLC

Risdiplam (Evrysdi)^O

Indicated to treat spinal muscular atrophy²

Genentech USA, Inc.

Sacituzumab govitecan (Trodelvy)^B,C

Indicated to treat adult patients with metastatic triple-negative breast cancer who received at least two prior therapies for metastatic disease²

Immunomedics Inc.

Satralizumab (Enspryng)^B,O

Indicated to treat neuromyelitis optica spectrum disorder¹

Hoffmann-La Roche Ltd

Selpercatinib (Retevmo)^C,O

Indicated to treat lung and thyroid cancers²

Eli Lilly and Co.

Selumetinib (Koselugo)^O

Indicated to treat neurofibromatosis type 1, a genetic disorder of the nervous system causing tumors to grow on nerves²

AstraZeneca

Setmelanotide (Imcivree)^O

Indicated to treat obesity and the control of hunger associated with pro-opiomelanocortin deficiency, a rare disorder that causes severe obesity that begins at an early age²

Rhythm Pharmaceuticals, Inc.

Somapacitan (Sogroya)^B

Indicated as a growth hormone²

Novo Nordisk, Inc.

Tafasitamab (Monjuvi)^B,C,O

Indicated to treat relapsed or refractory diffuse large B-cell lymphoma²

MorphoSys US, Inc.

Tazemetostat (Tazverik)^C,O

Indicated to treat epithelioid sarcoma²

Epizyme, Inc.

Teprotumumab (Tepezza)^B,O

Indicated to treat thyroid eye disease²

Horizon Therapeutics

Tirbanibulin (Klisyri)

Indicated to treat actinic Keratosis of the face or scalp²

Almirall

Triheptanoin (Dojolvi)^O

Indicated to treat molecularly long-chain fatty acid oxidation disorders²

Ultragenyx Pharmaceutical Inc.

Tucatinib (Tukysa)^C,O

Indicated to treat advanced unresectable or metastatic HER2-positive breast cancer²

Seagen Inc.

Vibegron (Gemtesa, Beova)

Indicated to treat overactive bladder²

Urovant Sciences

Viltolarsen (Viltepso)^O

Indicated to treat Duchenne muscular dystrophy²

NS Pharma, Inc.